von Luettichau I - Search Results

1

Genetically engineered stem cells for therapeutic gene delivery.

Conrad C, Gupta R, Mohan H, Niess H, Bruns CJ, Kopp R, von Luettichau I, Guba M, Heeschen C, Jauch KW, Huss R, Nelson PJ. Conrad C, et al. Among authors: von luettichau i. Curr Gene Ther. 2007 Aug;7(4):249-60. doi: 10.2174/156652307781369119. Curr Gene Ther. 2007. PMID: 17969558 Review.

2

Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesis.

Conrad C, Hüsemann Y, Niess H, von Luettichau I, Huss R, Bauer C, Jauch KW, Klein CA, Bruns C, Nelson PJ. Conrad C, et al. Among authors: von luettichau i. Ann Surg. 2011 Mar;253(3):566-71. doi: 10.1097/SLA.0b013e3181fcb5d8. Ann Surg. 2011. PMID: 21169810

3

Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo.

Conrad C, Niess H, Huss R, Huber S, von Luettichau I, Nelson PJ, Ott HC, Jauch KW, Bruns CJ. Conrad C, et al. Among authors: von luettichau i. Circulation. 2009 Jan 20;119(2):281-9. doi: 10.1161/CIRCULATIONAHA.108.793208. Epub 2008 Dec 31. Circulation. 2009. PMID: 19118255

4

CCR10 is expressed in cutaneous T-cell lymphoma.

Notohamiprodjo M, Segerer S, Huss R, Hildebrandt B, Soler D, Djafarzadeh R, Buck W, Nelson PJ, von Luettichau I. Notohamiprodjo M, et al. Among authors: von luettichau i. Int J Cancer. 2005 Jul 1;115(4):641-7. doi: 10.1002/ijc.20922. Int J Cancer. 2005. PMID: 15700309

5

A complex pattern of chemokine receptor expression is seen in osteosarcoma.

von Luettichau I, Segerer S, Wechselberger A, Notohamiprodjo M, Nathrath M, Kremer M, Henger A, Djafarzadeh R, Burdach S, Huss R, Nelson PJ. von Luettichau I, et al. BMC Cancer. 2008 Jan 24;8:23. doi: 10.1186/1471-2407-8-23. BMC Cancer. 2008. PMID: 18215331 Free PMC article.

6

TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis.

Djafarzadeh R, Milani V, Rieth N, von Luettichau I, Skrablin PS, Hofstetter M, Noessner E, Nelson PJ. Djafarzadeh R, et al. Among authors: von luettichau i. Cancer Immunol Immunother. 2009 Mar;58(3):361-71. doi: 10.1007/s00262-008-0559-5. Epub 2008 Jul 11. Cancer Immunol Immunother. 2009. PMID: 18618109 Free PMC article.

7

Mononuclear infiltrates in osteosarcoma and chemokine receptor expression.

von Luettichau I, Nathrath M, Burdach S, Huss R, Segerer S, Nelson PJ. von Luettichau I, et al. Clin Cancer Res. 2006 Sep 1;12(17):5253-4; author reply 5254. doi: 10.1158/1078-0432.CCR-06-0785. Clin Cancer Res. 2006. PMID: 16951246 No abstract available.

8

GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing.

Djafarzadeh R, Noessner E, Engelmann H, Schendel DJ, Notohamiprodjo M, von Luettichau I, Nelson PJ. Djafarzadeh R, et al. Among authors: von luettichau i. Oncogene. 2006 Mar 9;25(10):1496-508. doi: 10.1038/sj.onc.1209188. Oncogene. 2006. PMID: 16261161

9

Podoplanin increases migration and angiogenesis in malignant glioma.

Grau SJ, Trillsch F, Tonn JC, Goldbrunner RH, Noessner E, Nelson PJ, von Luettichau I. Grau SJ, et al. Among authors: von luettichau i. Int J Clin Exp Pathol. 2015 Jul 1;8(7):8663-70. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26339454 Free PMC article.

10

Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma.

Baumhoer D, Smida J, Zillmer S, Rosemann M, Atkinson MJ, Nelson PJ, Jundt G, von Luettichau I, Nathrath M. Baumhoer D, et al. Among authors: von luettichau i. Mod Pathol. 2012 Apr;25(4):522-8. doi: 10.1038/modpathol.2011.193. Epub 2011 Dec 16. Mod Pathol. 2012. PMID: 22173290 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters